Mr Scott Andrew

I am a third-year PhD student in the Payne group. My research focuses on the development of light-activated anticancer drugs. Specifically, I chemically modify macrocyclic compounds to fine-tune their photophysical and biological properties. These macrocycles absorb light at defined wavelengths and generate singlet oxygen, which can selectively damage cancer cells.

I am a synthetic organic chemist with experience in small-molecule synthesis, chemical analysis, and compound characterisation, as well as biological evaluation using cancer cell lines. My master’s degree was in chemical biology, where I developed skills in gene cloning and protein expression and purification. I previously completed an undergraduate degree in pharmaceutical science.

My research interests lie broadly in chemistry with medicinal and therapeutic applications.